FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 255

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
MRNA Nasdaq Moderna, Inc. 2830
MTNB NYSE American Matinas BioPharma Holdings, Inc. 2830
NAGE Nasdaq Niagen Bioscience, Inc. 2830
NEUP Nasdaq Neuphoria Therapeutics Inc. 2830
NIKI Nasdaq Niki BioSolutions, Inc. 2830
NKTR Nasdaq Nektar Therapeutics 2830
NMRA Nasdaq Neumora Therapeutics, Inc. 2830
NRIX Nasdaq Nurix Therapeutics, Inc. 2830
NSRX NYSE American Nasus Pharma Ltd. 2830
NTHI Nasdaq NeOnc Technologies Holdings, Inc. 2830
NUVB New York Nuvation Bio Inc. 2830
NVO New York Novo Nordisk A/S 2830
NVS New York Novartis AG 2830
OGEN NYSE American Oragenics, Inc. 2830
OGN New York Organon & Co. 2830
OKUR Nasdaq OnKure Therapeutics, Inc. 2830
OLMA Nasdaq Olema Pharmaceuticals, Inc. 2830
ONCO Nasdaq Onconetix, Inc. 2830
ONCY Nasdaq Oncolytics Biotech Inc. 2830
ORXOY Over the counter Orexo AB (publ) 2830
PBH New York Prestige Consumer Healthcare Inc. 2830
PBLS Nasdaq Parabilis Medicines, Inc. 2830
PDSB Nasdaq PDS Biotechnology Corporation 2830
PG New York The Procter & Gamble Company 2830
PHIO Nasdaq Phio Pharmaceuticals Corp. 2830
PHVS Nasdaq Pharvaris N.V. 2830
PLRX Nasdaq Pliant Therapeutics, Inc. 2830
PLYX Nasdaq Polaryx Therapeutics, Inc. 2830
PPBT Nasdaq Purple Biotech Ltd 2830
PPCB Nasdaq Propanc Biopharma, Inc. 2830
PRAX Nasdaq Praxis Precision Medicines, Inc. 2830
PTCT Nasdaq PTC Therapeutics, Inc. 2830
PTGX Nasdaq Protagonist Therapeutics, Inc. 2830
PTHS NYSE American Pelthos Therapeutics Inc. 2830
PULM Nasdaq Pulmatrix, Inc. 2830
QCLS Nasdaq Q/C Technologies, Inc. 2830
QNRX Nasdaq Quoin Pharmaceuticals, Ltd. 2830
QTRX Nasdaq Quanterix Corporation 2830
RANI Nasdaq Rani Therapeutics Holdings, Inc. 2830
RDHL Nasdaq RedHill Biopharma Ltd. 2830
RDY New York Dr. Reddys Laboratories Limited 2830
RFL New York Rafael Holdings, Inc. 2830
RLMD Nasdaq Relmada Therapeutics, Inc. 2830
RMTI Nasdaq Rockwell Medical, Inc. 2830
RNA Nasdaq Atrium Therapeutics, Inc. 2830
ROIV Nasdaq Roivant Sciences Ltd. 2830
RXRX Nasdaq Recursion Pharmaceuticals, Inc. 2830
RYTM Nasdaq Rhythm Pharmaceuticals, Inc. 2830
RZLT Nasdaq Rezolute, Inc. 2830
SCNX Nasdaq Scienture Holdings, Inc. 2830
Results 150 through 200 of 255